CCL3 and leukemia: Since CCL3 has previously been shown to be critical for the maintenance and emergence of leukemia initiating cells in multiple murine models, it will be important to evaluate any impact of CCL3 inhibition on the normal hematopoietic system as well as the malignancy being treated.